XIAMEN KINGDOMWAY GROUP COMPANY |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.55 CNY | +5.93% |
|
+12.68% | -4.78% |
| Sales 2022 | 3.01B 416M 33.24B | Sales 2023 | 3.1B 429M 34.27B | Capitalization | 9.96B 1.38B 110B |
|---|---|---|---|---|---|
| Net income 2022 | 257M 35.5M 2.84B | Net income 2023 | 277M 38.26M 3.06B | EV / Sales 2022 | 4.3 x |
| Net Debt 2022 | 293M 40.54M 3.24B | Net cash position 2023 | 16.47M 2.28M 182M | EV / Sales 2023 | 3.2 x |
| P/E ratio 2022 |
48.2
x | P/E ratio 2023 |
36.3
x | Employees | 2,907 |
| Yield 2022 |
0.97% | Yield 2023 |
-
| Free-Float | 40.42% |
More Fundamentals
* Assessed data
More news
| 1 day | +5.93% | ||
| 1 week | +12.68% | ||
| Current month | -0.77% | ||
| 1 month | -0.77% | ||
| 3 months | +14.51% | ||
| 6 months | -14.14% | ||
| Current year | -4.78% |
1 week
13.64
15.76
1 month
12.8015.76
Current year
10.7116.48
1 year
10.7121.16
3 years
10.7151.23
5 years
10.7164.48
10 years
8.1564.48
| Managers | Title | Age | Since |
|---|---|---|---|
Bin Jiang
CEO | Chief Executive Officer | 57 | 31/12/96 |
Hang Hong
DFI | Director of Finance/CFO | 42 | 11/04/16 |
Jia Liang Chen
BRD | Director/Board Member | 60 | 31/05/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Bin Jiang
CEO | Chief Executive Officer | 57 | 31/12/96 |
Jia Liang Chen
BRD | Director/Board Member | 60 | 31/05/01 |
Guo Qing Ma
PRN | Corporate Officer/Principal | 60 | 31/12/00 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.00% | 117 M€ | +0.53% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/04/24 | 15.55 | +5.93% | 17 578 300 |
| 29/04/24 | 14.68 | +5.23% | 9,486,137 |
| 26/04/24 | 13.95 | -0.78% | 6,477,183 |
| 25/04/24 | 14.06 | +1.88% | 4,991,300 |
| 24/04/24 | 13.8 | -0.22% | 4,522,433 |
End-of-day quote Shenzhen S.E., April 29, 2024
More quotes
Xiamen Kingdomway Group Company is a China-based company principally engaged in the production and distribution of nutrition enhancers and health care products. The Company mainly provides coenzyme Q10 series, including coenzyme Q10 lotion and Q10 powder; vitamin A (VA) series, including food level VA acetate, food level VA palmitate, food level VA palmitate powder, food level VA acetate powder, feed level VA powder and feed level VA acetate oil; health products - capsules series, as well as health products - tablets series, among others. The Company distributes its products within domestic market and to overseas markets.
Sector
Food Processing
Calendar
29/04/2024
- Q1 2024 Earnings Release
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -4.78% | 1.24B | |
| +13.21% | 8.01B | |
| +1.64% | 7.36B | |
| +12.30% | 6.54B | |
| -6.99% | 3.73B | |
| -7.27% | 3.42B | |
| +12.61% | 935M | |
| -41.84% | 886M | |
| -21.53% | 827M | |
| -17.33% | 804M |
- Stock Market
- Equities
- 002626 Stock
